Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NuuVim vs Trimi

NuuVim
Graded #101

Lower grade

vs+15.300000000000011
Trimi
Graded #7

Higher grade

The verdict

Trimi takes it — 86.4/100 to 71.1/100.

Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bottom-quartile pricing on both molecules under one flat membership, shipped free nationwide — a strong-value pick sitting just behind the top tier.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNuuVim +4
97
93
Dose & formulationNuuVim +12
96
84
Clinical oversightTrimi +40
42
82
Labs & monitoringTrimi +33
50
83
FulfillmentTrimi +29
61
90
Contract termsTrimi +29
55
84
NuuVim · left barTrimi · right bar

The numbers

MetricNuuVimTrimi
WeighScore71.1/10086.4/100
GradeCB
Scorecard rank#101#7
Semaglutide$79/mo (all doses, compounded)$129/mo
Tirzepatide$133/mo (all doses, compounded)$199/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
NuuVim

Graded #101 · C

Strengths

  • Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
  • Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
  • LegitScript Certified and HIPAA-compliant
  • Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
  • Operating legal entity disclosed: NuuVim LLC, Texas governing law

Where it loses points

  • No founder, CEO, medical director, or pharmacist-in-charge named
  • Refund and cancellation policy not surfaced on the site
  • Compounded medications are not FDA-approved
  • Doesn't disclose which pharmacy fills which drug or form
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Trimi

Graded #7 · B

Strengths

  • Low flat pricing on both semaglutide and tirzepatide
  • Both molecules on a single membership
  • Free shipping to all 50 states
  • Fast dispatch once the prescriber signs off

Where it loses points

  • Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
  • Injection only — no oral or sublingual route
  • Dispensing pharmacy not publicly named
  • Shorter public track record than the incumbents

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard